{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:55:03Z","timestamp":1791608103060,"version":"4.3.4"},"reference-count":73,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":61,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF14OC0011537"],"award-info":[{"award-number":["NNF14OC0011537"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001732","name":"Danmarks Grundforskningsfond","doi-asserted-by":"publisher","award":["DNRF141"],"award-info":[{"award-number":["DNRF141"]}],"id":[{"id":"10.13039\/501100001732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["4004-001"],"award-info":[{"award-number":["4004-001"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.gastha.2023.03.006","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T20:59:20Z","timestamp":1678222760000},"page":"711-720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Obese Patients With Nonalcoholic Fatty Liver Disease Have an Increase in Soluble Plasma CD163 and a Concurrent Decrease in Hepatic Expression of CD163"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1366-2911","authenticated-orcid":false,"given":"Maria Kl\u00f8jgaard","family":"Skytthe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix Boel","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte Wilhelmina","family":"Wernberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineesh","family":"Indira Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Krag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Di Caterino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Coelho","family":"Mandacaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blagoy","family":"Blagoev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette Munk","family":"Lauridsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6nke","family":"Detlefsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas Heilskov","family":"Graversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren Kragh","family":"Moestrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.gastha.2023.03.006_bib1","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.gastha.2023.03.006_bib2","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep4.1479","article-title":"Pathogenesis of nonalcoholic steatohepatitis: an overview","volume":"4","author":"Parthasarathy","year":"2020","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.gastha.2023.03.006_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41423-020-00579-3","article-title":"Immunological mechanisms and therapeutic targets of fatty liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"10.1016\/j.gastha.2023.03.006_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gastha.2023.03.006_bib5","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.molcel.2019.07.028","article-title":"Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis","volume":"75","author":"Xiong","year":"2019","journal-title":"Mol Cell"},{"key":"10.1016\/j.gastha.2023.03.006_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cellimm.2017.10.006","article-title":"Non-alcoholic steatohepatitis induces transient changes within the liver macrophage pool","volume":"322","author":"Devisscher","year":"2017","journal-title":"Cell Immunol"},{"issue":"5","key":"10.1016\/j.gastha.2023.03.006_bib7","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1194\/jlr.M034876","article-title":"Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis","volume":"54","author":"Ioannou","year":"2013","journal-title":"J\u00a0Lipid Res"},{"issue":"12","key":"10.1016\/j.gastha.2023.03.006_bib8","doi-asserted-by":"crossref","first-page":"e82163","DOI":"10.1371\/journal.pone.0082163","article-title":"Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans","volume":"8","author":"Itoh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.gastha.2023.03.006_bib9","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.3389\/fimmu.2019.02852","article-title":"Therapeutic targeting of hepatic macrophages for the treatment of liver diseases","volume":"10","author":"van der Heide","year":"2019","journal-title":"Front Immunol"},{"issue":"6817","key":"10.1016\/j.gastha.2023.03.006_bib10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/35051594","article-title":"Identification of the haemoglobin scavenger receptor","volume":"409","author":"Kristiansen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.gastha.2023.03.006_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.omtm.2016.11.004","article-title":"Antibody-directed Glucocorticoid targeting to CD163 in M2-type macrophages attenuates Fructose-induced liver inflammatory changes","volume":"4","author":"Svendsen","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"6","key":"10.1016\/j.gastha.2023.03.006_bib12","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1189\/jlb.0410235","article-title":"Tumor necrosis factor \u03b1-converting enzyme (TACE\/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163","volume":"88","author":"Etzerodt","year":"2010","journal-title":"J\u00a0Leukoc Biol"},{"issue":"1","key":"10.1016\/j.gastha.2023.03.006_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00365513.2011.626868","article-title":"Soluble CD163","volume":"72","author":"M\u00f8ller","year":"2012","journal-title":"Scand J Clin Lab Invest"},{"issue":"12","key":"10.1016\/j.gastha.2023.03.006_bib14","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/oby.20376","article-title":"The macrophage-specific serum marker, soluble CD163, is increased in obesity and reduced after dietary-induced weight loss","volume":"21","author":"Fjeldborg","year":"2013","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"10.1016\/j.gastha.2023.03.006_bib15","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1007\/s00125-012-2533-1","article-title":"Soluble CD163: a biomarker linking macrophages and insulin resistance","volume":"55","author":"Parkner","year":"2012","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.gastha.2023.03.006_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2265.2011.04284.x","article-title":"Relationship between monocyte\/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects","volume":"77","author":"Zanni","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.gastha.2023.03.006_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1373\/clinchem.2010.154724","article-title":"Serum soluble CD163 predicts risk of type 2 diabetes in the general population","volume":"57","author":"M\u00f8ller","year":"2011","journal-title":"Clin Chem"},{"issue":"9","key":"10.1016\/j.gastha.2023.03.006_bib18","doi-asserted-by":"crossref","first-page":"e13257","DOI":"10.1111\/obr.13257","article-title":"The association of soluble CD163, a novel biomarker of macrophage activation, with type 2 diabetes mellitus and its underlying physiological disorders: a systematic review","volume":"22","author":"Semnani-Azad","year":"2021","journal-title":"Obes Rev"},{"issue":"15","key":"10.1016\/j.gastha.2023.03.006_bib19","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.3390\/ijms21155497","article-title":"Targeting of CD163(+) macrophages in inflammatory and Malignant diseases","volume":"21","author":"Skytthe","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.gastha.2023.03.006_bib20","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1038\/ctg.2015.36","article-title":"Circulating soluble CD163 is associated with steatohepatitis and advanced fibrosis in nonalcoholic fatty liver disease","volume":"6","author":"Mueller","year":"2015","journal-title":"Clin Transl Gastroenterol"},{"issue":"5","key":"10.1016\/j.gastha.2023.03.006_bib21","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jhep.2019.06.031","article-title":"Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease","volume":"71","author":"Rosso","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.gastha.2023.03.006_bib22","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/jgh.12943","article-title":"Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery","volume":"30","author":"Kazankov","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.gastha.2023.03.006_bib23","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/liv.13150","article-title":"The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease","volume":"36","author":"Kazankov","year":"2016","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.gastha.2023.03.006_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.dsx.2020.11.023","article-title":"Performance of serum CD163 as a marker of fibrosis in patients with NAFLD","volume":"15","author":"Ragab","year":"2021","journal-title":"Diabetes Metab Syndr"},{"issue":"9","key":"10.1016\/j.gastha.2023.03.006_bib25","first-page":"2271","article-title":"Clinical progression of metabolic-associated fatty liver disease is Rare in a Danish tertiary liver center","volume":"11","author":"Laursen","year":"2022","journal-title":"J\u00a0Clin Med"},{"issue":"7","key":"10.1016\/j.gastha.2023.03.006_bib26","doi-asserted-by":"crossref","first-page":"e0270911","DOI":"10.1371\/journal.pone.0270911","article-title":"The performance of soluble CD163 as a non-invasive biomarker of liver damage in chronically HCV and HCV\/HIV infected subjects","volume":"17","author":"Cairoli","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.gastha.2023.03.006_bib27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/hep.27129","article-title":"Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C","volume":"60","author":"Kazankov","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gastha.2023.03.006_bib28","doi-asserted-by":"crossref","first-page":"10264","DOI":"10.1038\/s41598-018-28483-x","article-title":"Iron-overload triggers ADAM-17 mediated inflammation in severe alcoholic hepatitis","volume":"8","author":"Maras","year":"2018","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.gastha.2023.03.006_bib29","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/ajg.2014.262","article-title":"Hepatic macrophage activation and the LPS pathway in patients with alcoholic hepatitis: a prospective cohort study","volume":"109","author":"Sandahl","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gastha.2023.03.006_bib30","doi-asserted-by":"crossref","first-page":"e00315","DOI":"10.14309\/ctg.0000000000000315","article-title":"Circulating macrophage activation markers predict transplant-Free survival in patients with primary sclerosing cholangitis","volume":"12","author":"Bossen","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"issue":"6","key":"10.1016\/j.gastha.2023.03.006_bib31","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/liv.14466","article-title":"Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis","volume":"40","author":"Bossen","year":"2020","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.gastha.2023.03.006_bib32","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/jgh.15125","article-title":"Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation","volume":"36","author":"Gr\u00f8nbaek","year":"2021","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.gastha.2023.03.006_bib33","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3390\/cells9051175","article-title":"Macrophage activation markers, CD163 and CD206, in acute-on-chronic liver failure","volume":"9","author":"Nielsen","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.gastha.2023.03.006_bib34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jhep.2013.06.008","article-title":"Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma","volume":"59","author":"Waidmann","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.gastha.2023.03.006_bib35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/00365513.2015.1099722","article-title":"Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma","volume":"76","author":"Kazankov","year":"2016","journal-title":"Scand J Clin Lab Invest"},{"issue":"9","key":"10.1016\/j.gastha.2023.03.006_bib36","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/QAD.0000000000002869","article-title":"Decreases in markers of monocyte\/macrophage activation after hepatitis C eradication in HIV\/hepatitis C virus coinfected women","volume":"35","author":"French","year":"2021","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.gastha.2023.03.006_bib37","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1080\/00365521.2018.1481996","article-title":"Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology","volume":"53","author":"Lund Laursen","year":"2018","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.gastha.2023.03.006_bib38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/jgh.13849","article-title":"Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment","volume":"33","author":"Laursen","year":"2018","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gastha.2023.03.006_bib39","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/ijpo.252","article-title":"The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children","volume":"10","author":"Kazankov","year":"2015","journal-title":"Pediatr Obes"},{"issue":"7","key":"10.1016\/j.gastha.2023.03.006_bib40","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/00365513.2017.1346823","article-title":"Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease","volume":"77","author":"R\u00f8dgaard-Hansen","year":"2017","journal-title":"Scand J Clin Lab Invest"},{"issue":"4","key":"10.1016\/j.gastha.2023.03.006_bib41","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/cells6040048","article-title":"Differential location and distribution of hepatic immune cells","volume":"6","author":"Freitas-Lopes","year":"2017","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.gastha.2023.03.006_bib42","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/hep.31215","article-title":"Transcriptional dynamics of hepatic sinusoid-associated cells after liver injury","volume":"72","author":"Terkelsen","year":"2020","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.gastha.2023.03.006_bib43","doi-asserted-by":"crossref","first-page":"108626","DOI":"10.1016\/j.celrep.2020.108626","article-title":"Dynamic shifts in the composition of resident and Recruited macrophages influence tissue Remodeling in NASH","volume":"34","author":"Daemen","year":"2021","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.gastha.2023.03.006_bib44","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.immuni.2020.04.001","article-title":"Niche-Specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis","volume":"52","author":"Seidman","year":"2020","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.gastha.2023.03.006_bib45","doi-asserted-by":"crossref","first-page":"G462","DOI":"10.1152\/ajpgi.00358.2018","article-title":"Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals","volume":"316","author":"Suppli","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"7","key":"10.1016\/j.gastha.2023.03.006_bib46","doi-asserted-by":"crossref","first-page":"e22372","DOI":"10.1096\/fj.202200346R","article-title":"A\u00a0new preclinical model of western diet-induced progression of non-alcoholic steatohepatitis to hepatocellular carcinoma","volume":"36","author":"Green","year":"2022","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.gastha.2023.03.006_bib47","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12876-020-01356-2","article-title":"Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis","volume":"20","author":"Hansen","year":"2020","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"10.1016\/j.gastha.2023.03.006_bib61","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.gastha.2023.03.006_bib62","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/003655102760145852","article-title":"Characterization of an enzyme-linked immunosorbent assay for soluble CD163","volume":"62","author":"M\u00f8ller","year":"2002","journal-title":"Scand J Clin Lab Invest"},{"issue":"6","key":"10.1016\/j.gastha.2023.03.006_bib48","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.gastha.2023.03.006_bib63","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/hep.25889","article-title":"Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients","volume":"56","author":"Bedossa","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.gastha.2023.03.006_bib64","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/hep.27173","article-title":"Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease","volume":"60","author":"Bedossa","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gastha.2023.03.006_bib65","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.gastha.2023.03.006_bib66","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1074\/mcp.TIR118.001270","article-title":"Protein aggregation capture on microparticles enables Multipurpose proteomics sample preparation","volume":"18","author":"Batth","year":"2019","journal-title":"Mol Cell Proteomics"},{"issue":"8","key":"10.1016\/j.gastha.2023.03.006_bib67","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.cmet.2021.06.005","article-title":"Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication","volume":"33","author":"Loft","year":"2021","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.gastha.2023.03.006_bib68","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41598-020-58059-7","article-title":"Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis","volume":"10","author":"\u00c6gidius","year":"2020","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.gastha.2023.03.006_bib69","doi-asserted-by":"crossref","first-page":"e8126","DOI":"10.15252\/msb.20178126","article-title":"Data-independent acquisition-based SWATH-MS for quantitative proteomics: a tutorial","volume":"14","author":"Ludwig","year":"2018","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.gastha.2023.03.006_bib49","doi-asserted-by":"crossref","first-page":"100615","DOI":"10.1016\/j.jhepr.2022.100615","article-title":"Stellate cell expression of SPARC-related modular calcium-binding protein 2 is associated with human non-alcoholic fatty liver disease severity","volume":"5","author":"Larsen","year":"2022","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.gastha.2023.03.006_bib70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.gastha.2023.03.006_bib71","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.gastha.2023.03.006_bib72","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.gastha.2023.03.006_bib73","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.gastha.2023.03.006_bib50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neulet.2017.09.034","article-title":"ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157","volume":"660","author":"Feuerbach","year":"2017","journal-title":"Neurosci Lett"},{"issue":"5","key":"10.1016\/j.gastha.2023.03.006_bib51","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/MPG.0000000000002111","article-title":"Macrophage markers are poorly associated with liver histology in children with nonalcoholic fatty liver disease","volume":"67","author":"Kazankov","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gastha.2023.03.006_bib52","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000000270","article-title":"Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression","author":"Guillot","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.gastha.2023.03.006_bib53","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.immuni.2020.08.004","article-title":"Osteopontin expression identifies a subset of Recruited macrophages distinct from Kupffer cells in the fatty liver","volume":"53","author":"Remmerie","year":"2020","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.gastha.2023.03.006_bib54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cgh.2020.04.067","article-title":"Women have a lower risk of nonalcoholic fatty liver disease but a higher risk of progression vs men: a systematic review and meta-analysis","volume":"19","author":"Balakrishnan","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gastha.2023.03.006_bib55","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1089\/lap.2014.0639","article-title":"Benefits of bariatric surgery do not reach obese men","volume":"25","author":"Fuchs","year":"2015","journal-title":"J\u00a0Laparoendosc Adv Surg Tech A"},{"issue":"7","key":"10.1016\/j.gastha.2023.03.006_bib56","doi-asserted-by":"crossref","first-page":"e101327","DOI":"10.1371\/journal.pone.0101327","article-title":"Elevated soluble CD163 in gestational diabetes mellitus: secretion from human placenta and adipose tissue","volume":"9","author":"Bari","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.gastha.2023.03.006_bib57","doi-asserted-by":"crossref","first-page":"E528","DOI":"10.1210\/jc.2013-3348","article-title":"Soluble CD163 is associated with CD163 mRNA expression in adipose tissue and with insulin sensitivity in steady-state condition but not in response to calorie restriction","volume":"99","author":"Kra\u010dmerov\u00e1","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.gastha.2023.03.006_bib58","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/hep.32620","article-title":"Circulating TREM2 as a non-invasive diagnostic biomarker for NASH in patients with elevated liver stiffness","volume":"77","author":"Chandran","year":"2022","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.gastha.2023.03.006_bib59","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jhep.2022.06.004","article-title":"Soluble TREM2 levels reflect the recruitment and expansion of TREM2(+) macrophages that localize to fibrotic areas and limit NASH","volume":"77","author":"Hendrikx","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.gastha.2023.03.006_bib60","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1111\/jgh.15631","article-title":"Circulating tumor necrosis factor-\u03b1 levels in non-alcoholic fatty liver disease: a systematic review and a meta-analysis","volume":"36","author":"Potoupni","year":"2021","journal-title":"J\u00a0Gastroenterol Hepatol"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572323000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572323000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:35:18Z","timestamp":1757417718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572323000419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"alternative-id":["S2772572323000419"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2023.03.006","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obese Patients With Nonalcoholic Fatty Liver Disease Have an Increase in Soluble Plasma CD163 and a Concurrent Decrease in Hepatic Expression of CD163","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2023.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}